A carregar...
Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial
We previously demonstrated the safety and feasibility of mesenchymal stem cell (MSC) transplantation for bronchopulmonary dysplasia (BPD) in preterm infants in a phase I clinical trial. We thus investigated the therapeutic efficacy of MSCs for BPD in premature infants. A phase II double‐blind, rando...
Na minha lista:
| Publicado no: | Stem Cells Transl Med |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8284779/ https://ncbi.nlm.nih.gov/pubmed/33876883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0330 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|